EYE 0.00% 24.5¢ nova eye medical limited

Nova Eye Medical (EYE) Discussion, page-19

  1. 622 Posts.
    lightbulb Created with Sketch. 156
    I’m sure the NEU announcement should bring a bit of love to the sector! Definitely seems like EYE has a bit more going for it with a device (in the high growth MIGS market, CAGR 20%) that is already approved and a potential first ever treatment for a much more common disease

    Correct me if I am wrong but…

    • $30m market cap ONLY
    • Revenue generating ($15m LTM, 28% growth, new product that will drive significantly higher revenue growth for CY23)
    • Exciting R&D pipeline —> seeking FDA approval for the first ever treatment for intermediate AMD (affecting 1 in 7 people and the leading cause of blindness)

    EYE seems a bit cheap don’t ya reckon
    Last edited by TreasureHunterr: 13/03/23
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.